K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Pathophysiology of ANCA-associated vasculitis: are ANCA really pathogenic? A note of caution.

1. MANJUNATH G, SARNAK MJ, LEVEY AS: Prediction equations to estimate glomerular filtration rate: An update. Curr Opin Nephrol Hypertens 10:785–792, 2001 2. NATIONAL KIDNEY FOUNDATION: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39(Suppl 1):S1–266, 2002 3. KEITH DS, NICHOLS GA, GULLION CM, et al: Longitudinal fo...

Tubulointerstitial disease and ulcerative colitis

1. Ball P. Ciprofloxacin: an overview of adverse experiences. J Antimicrob Chemother 1986; [Suppl D]: 187–193 2. Thorsteinsson SB, Bergan T, Oddsdottir S, Rohwedder R, Holm R. Crystalluria and ciprofloxacin, influence of urinary PH and hydration. Chemotherapy 1986; 32: 408–417 3. National Kidney Foundation, K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classificati...

K/DOQI Clinical Practice Guidelines for Managing Dyslipidemias in Chronic Kidney Disease

........................................................................................................................... S10

K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Children With Chronic Kidney Disease

Barriers to successful care for chronic kidney disease

BACKGROUND The National Kidney Foundation has formulated clinical practice guidelines for patients with chronic kidney disease (K/DOQI). However, little is know about how many patients actually achieve these goals in a dedicated clinic for chronic kidney disease. METHODS We performed a cross-sectional analysis of 198 patients with an estimated glomerular filtration rate of less than 30 ml/min...